Inmuno-oncología e Inmunoterapia |

Publicaciones

2023

Antunes, A, Alvarez-Vallina, L, Bertoglio, F, Bouquin, N, Cornen, S, Duffieux, F, Ferré, P, Gillet, R, Jorgensen, C, Leick, MB, Maillère, B, Negre, H, Pelegrin, M, Poirier, N, Reusch, D, Robert, B, Serre, G, Vicari, A, Villalba, M, Volpers, C, Vuddamalay, G, Watier, H, Wurch, T, Zabeau, L, Zielonka, S, Zhang, BL, Beck, A, Martineau, P (2023).

10th antibody industrial symposium: new developments in antibody and adoptive cell therapies

MABS. Article. 15(1).
[doi:10.1080/19420862.2023.2211692]

Rubio-Pérez, L, Lázaro-Gorines, R, Harwood, SL, Compte, M, Navarro, R, Tapia-Galisteo, A, Bonet, J, Blanco, B, Lykkemark, S, Ramírez-Fernández, A, Ferreras-Gutiérrez, M, Domínguez-Alonso, C, Díez-Alonso, L, Segura-Tudela, A, Hangiu, O, Erce-Llamazares, A, Blanco, FJ, Santos, C, Rodríguez-Peralto, JL, Sanz, L, Alvarez-Vallina, L (2023).

A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response

OncoImmunology. Article. 12(1).
[doi:10.1080/2162402X.2023.2205336]

Lázaro-Gorines, R, Pérez, P, Heras-Murillo, I, Adán-Barrientos, I, Albericio, G, Astorgano, D, Flores, S, Luczkowiak, J, Labiod, N, Harwood, SL, Segura-Tudela, A, Rubio-Pérez, L, Nugraha, Y, Shang, XR, Li, YX, Alfonso, C, Adipietro, KA, Abeyawardhane, DL, Navarro, R, Compte, M, Yu, WB, Mackerell, AD Jr, Sanz, L, Weber, DJ, Blanco, FJ, Esteban, M, Pozharski, E, Godoy-Ruiz, R, Muñoz, IG, Delgado, R, Sancho, D, Garcia-Arriaza, J, Alvarez-Vallina, L (2023).

Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

Advanced Science. Article. 10(34).
[doi:10.1002/advs.202304818]

Tapia-Galisteo, A, Alvarez-Vallina, L, Sanz, L (2023).

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies

JOURNAL OF HEMATOLOGY & ONCOLOGY. Review. 16(1).
[doi:10.1186/s13045-023-01482-w]

Tapia-Galisteo, A, Compte, M, alvarez-Vallina, L, Sanz, L (2023).

When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy.

THERANOSTICS. Review. 13(3):1028-1041.
[doi:10.7150/thno.81494]

Lopez-Nevado, M, Ortiz-Martin, J, Serrano, C, Perez-Saez, MA, Lopez-Lorenzo, JL, Gil-Etayo, FJ, Rodriguez-Frias, E, Cabrera-Marante, O, Morales-Perez, P, Rodriguez-Pinilla, MS, Manso, R, Salgado-Sanchez, RN, Cerda-Montagud, A, Quesada-Espinosa, JF, Gomez-Rodriguez, MJ, Paz-Artal, E, Munoz-Calleja, C, Arranz-Saez, R, Allende, LM (2023).

Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy

JOURNAL OF CLINICAL IMMUNOLOGY. Article. 43(1):165-180.
[doi:10.1007/s10875-022-01361-y]

2022

Carrasco-Padilla, C, Hernaiz-Esteban, A, alvarez-Vallina, L, Aguilar-Sopena, O, Roda-Navarro, P (2022).

Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy.

Pharmaceutics. Review. 15(1).
[doi:10.3390/pharmaceutics15010132]

Jimenez-Reinoso, A, Tirado, N, Martinez-Moreno, A, Diaz, VM, Garcia-Peydro, M, Hangiu, O, Diez-Alonso, L, Albitre, A, Penela, P, Toribio, ML, Menendez, P, Alvarez-Vallina, L, Martinez, DS (2022).

Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers

Journal For Immunotherapy Of Cancer. Article. 10(12).
[doi:10.1136/jitc-2022-005333]

Marin, AV, Jimenez-Reinoso, A, Mazariegos, MS, Roman-Ortiz, E, Regueiro, JR (2022).

T-cell receptor signaling in Schimke immuno-osseous dysplasia is SMARCAL1-independent.

Frontiers in immunology. Article. 13:979722-979722.
[doi:10.3389/fimmu.2022.979722]

Hangiu, O, Compte, M, Dinesen, A, Navarro, R, Tapia-Galisteo, A, Mandrup, OA, Erce-Llamazares, A, Lazaro-Gorines, R, Nehme-Alvarez, D, Dominguez-Alonso, C, Harwood, SL, Alfonso, C, Blanco, B, Rubio-Perez, L, Jimenez-Reinoso, A, Diez-Alonso, L, Blanco, FJ, Sanz, L, Howard, KA, Alvarez-Vallina, L (2022).

Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity

iScience. Article. 25(9):104958-104958.
[doi:10.1016/j.isci.2022.104958]

Blanco B, Ramírez-Fernández Á, Bueno C, Argemí-Muntadas L, Fuentes P, Aguilar-Sopeña Ó, Gutierrez-Agüera F, Zanetti SR, Tapia-Galisteo A, Díez-Alonso L, Segura-Tudela A, Castellà M, Marzal B, Betriu S, Harwood SL, Compte M, Lykkemark S, Erce-Llamazares A, Rubio-Pérez L, Jiménez-Reinoso A, Domínguez-Alonso C, Neves M, Morales P, Paz-Artal E, Guedan S, Sanz L, Toribio ML, Roda-Navarro P, Juan M, Menéndez P, Álvarez-Vallina L (2022).

Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Cancer Immunology Research. Article. 10(4):498-511.
[doi:10.1158/2326-6066.CIR-21-0853]

Ramírez-Fernández Á, Aguilar-Sopeña Ó, Díez-Alonso L, Segura-Tudela A, Domínguez-Alonso C, Roda-Navarro P, Álvarez-Vallina L, Blanco B (2022).

Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies.

OncoImmunology. Article. 11(1):2054106-2054106.
[doi:10.1080/2162402X.2022.2054106]

Tapia-Galisteo A, Sánchez Rodríguez Í, Aguilar-Sopeña O, Harwood SL, Narbona J, Ferreras Gutierrez M, Navarro R, Martín-García L, Corbacho C, Compte M, Lacadena J, Blanco FJ, Chames P, Roda-Navarro P, Álvarez-Vallina L, Sanz L (2022).

Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.

OncoImmunology. Article. 11(1):2034355-2034355.
[doi:10.1080/2162402X.2022.2034355]

Paredes-Ruiz D, Gómez-Cuervo C, Gómez-Martín C, Sánchez-Guerrero Á, González-Olmedo J, López-López F, Bover-Larroya M, Yarza-Barrio R, Jara-Casas DD, Castelo-Laureiro A, Revilla-Ostolaza Y, Paz-Ares L, Lumbreras-Bermejo C, Díaz-Pedroche C (2022).

Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid

JOURNAL OF THROMBOSIS AND THROMBOLYSIS. Article. 53(2):1-8.
[doi:10.1007/s11239-021-02448-w]

Gil-Etayo FJ, Garcinuño S, Utrero-Rico A, Cabrera-Marante O, Arroyo-Sanchez D, Mancebo E, Pleguezuelo DE, Rodríguez-Frías E, Allende LM, Morales-Pérez P, Castro-Panete MJ, Lalueza A, Lumbreras C, Paz-Artal E, Serrano A (2022).

An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution.

Biomedicines. Article. 10(2).
[doi:10.3390/biomedicines10020296]

Compte, M, Sanz, L, Alvarez-Vallina, L (2022).

Applications of trimerbodies in cancer immunotherapy

International Review of Cell and Molecular Biology. Article. 369:71-87.
[doi:10.1016/bs.ircmb.2022.03.008]

2021

Sanz, L, Alvarez-Vallina, L (2021).

Engineered mRNA and the Rise of Next-Generation Antibodies

Antibodies. Article. 10(4).
[doi:10.3390/antib10040037]

Blanco B, Domínguez-Alonso C, Alvarez-Vallina L (2021).

Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy.

CLINICAL CANCER RESEARCH. Review. 27(20):5457-5464.
[doi:10.1158/1078-0432.CCR-20-3770]

Garcillan, B, Fuentes, P, Marin, AV, Megino, RF, Chacon-Arguedas, D, Mazariegos, MS, Jimenez-Reinoso, A, Munoz-Ruiz, M, Laborda, RG, Cardenas, PP, Fernandez-Malave, E, Toribio, ML, Regueiro, JR (2021).

CD3G or CD3D Knockdown in Mature, but Not Immature, T Lymphocytes Similarly Cripples the Human TCR alpha beta Complex

Frontiers In Cell And Developmental Biology. Article. 9.
[doi:10.3389/fcell.2021.608490]

Yarza R, Bover M, Agulló-Ortuño MT, Iglesias-Docampo LC (2021).

Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. Review. 40(1):202-202.
[doi:10.1186/s13046-021-02010-9]

Rousso-Noori L, Mastandrea I, Talmor S, Waks T, Globerson Levin A, Haugas M, Teesalu T, Alvarez-Vallina L, Eshhar Z, Friedmann-Morvinski D (2021).

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas.

NATURE COMMUNICATIONS. Article. 12(1):3615-3615.
[doi:10.1038/s41467-021-23817-2]

Compte M, Harwood SL, Erce-Llamazares A, Tapia-Galisteo A, Romero E, Ferrer I, Garrido-Martin EM, Enguita AB, Ochoa MC, Blanco B, Oteo M, Merino N, Nehme-Álvarez D, Hangiu O, Domínguez-Alonso C, Zonca M, Ramírez-Fernández A, Blanco FJ, Morcillo MA, Munoz, IG, Melero I, Rodriguez-Peralto JL, Paz-Ares L, Sanz L, Alvarez-Vallina L (2021).

An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity

CLINICAL CANCER RESEARCH. Article. 27(11):3167-3177.
[doi:10.1158/1078-0432.CCR-20-4625]

López-Nevado M, Docampo-Cordeiro J, Ramos JT, Rodríguez-Pena R, Gil-López C, Sánchez-Ramón S, Gil-Herrera J, Díaz-Madroñero MJ, Delgado-Martín MA, Morales-Pérez P, Paz-Artal E, Magerus A, Rieux-Laucat F, Allende LM (2021).

Next Generation Sequencing for Detecting Somatic FAS Mutations in Patients With Autoimmune Lymphoproliferative Syndrome.

Frontiers in immunology. Article. 12:656356-656356.
[doi:10.3389/fimmu.2021.656356]

Arteche-Lopez, A, Rodriguez, MJG, Calvin, MTS, Quesada-Espinosa, JF, Rosales, JML, Milla, CP, Gomez-Manjon, I, Mayoral, IH, de la Fuente, RP, de Bustamante, AD, Darnaude, MT, Gil-Fournier, B, Leon, SR, Gomez, PR, Tomillo, OS, Rufian, AJ, Cano, MIA, Alonso, RV, Morales-Perez, P, Segura-Tudela, A, Camacho, A, Nunez, N, Simon, R, Moreno-Garcia, M, Alvarez-Mora, MI (2021).

Towards a Change in the Diagnostic Algorithm of Autism Spectrum Disorders: Evidence Supporting Whole Exome Sequencing as a First-Tier Test

Genes. Article. 12(4).
[doi:10.3390/genes12040560]

Mandrup OA, Ong SC, Lykkemark S, Dinesen A, Rudnik-Jansen I, Dagnæs-Hansen NF, Andersen JT, Alvarez-Vallina L, Howard KA (2021).

Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinity.

Communications Biology. Article. 4(1):310-310.
[doi:10.1038/s42003-021-01790-2]

Martín-Soberón MC, Ruiz S, De Velasco G, Yarza R, Carretero A, Castellano D, Sepúlveda-Sánchez JM (2021).

Pneumatosis intestinalis in a radioactive iodine-refractory metastasic thyroid papillary carcinoma with BRAF(V600E) mutation treated with dabrafenib-trametinib: a case report.

Journal Of Medical Case Reports. Article. 15(1):109-109.
[doi:10.1186/s13256-020-02581-9]

Jiménez-Reinoso A, Nehme-Álvarez D, Domínguez-Alonso C, Álvarez-Vallina L (2021).

Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential.

Frontiers in oncology. Review. 10:593848-593848.
[doi:10.3389/fonc.2020.593848]

Compte M, Harwood SL, Martínez-Torrecuadrada J, Perez-Chacon G, González-García P, Tapia-Galisteo A, Van Bergen En Henegouwen PMP, Sánchez A, Fabregat I, Sanz L, Zapata JM, Alvarez-Vallina L (2021).

Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR.

Frontiers in immunology. Case Reports. 11:614363-614363.
[doi:10.3389/fimmu.2020.614363]

2020

Laguna-Goya, R, Utrero-Rico, A, Talayero, P, Lasa-Lazaro, M, Ramirez-Fernandez, A, Naranjo, L, Segura-Tudela, A, Cabrera-Marante, O, Rodriguez de Frias E, Garcia-Garcia, R, Fernandez-Ruiz, M, Aguado, JM, Martinez-Lopez, J, Lopez, EA, Catalan, M, Serrano, A, Paz-Artal, E (2020).

IL-6-based mortality risk model for hospitalized patients with COVID-19.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Article. 146(4):799.
[doi:10.1016/j.jaci.2020.07.009]

Navarro, R, Tapia-Galisteo, A, Martin-Garcia, L, Tarin, C, Corbacho, C, Gomez-Lopez, G, Sanchez-Tirado, E, Campuzano, S, Gonzalez-Cortes, A, Yáñez-Sedeño P, Compte, M, Alvarez-Vallina, L, Sanz, L (2020).

TGF-ß-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion.

MOLECULAR ONCOLOGY. Article. 14(10):2609-2628.
[doi:10.1002/1878-0261.12779]

Tolosa, P, Sanchez-Torre, A, de Cabo, HB, Sanchez-Bayona, R, Herrera, M, Yarza, R, Lema, L, Manso, L, Ciruelos, E (2020).

Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2-mBC patients during the pandemic.

CLINICAL CANCER RESEARCH. Meeting Abstract. 26(18).

Yarza, R, Bover, M, Paredes, D, Lopez-Lopez, F, Jara-Casas, D, Castelo-Loureiro, A, Baena, J, Mazarico, JM, Folgueira, MD, Melendez-Carmo, MA, Reyes, A, Lumbreras, C, Paz-Ares, L, Diaz-Pedroche, C, Gomez-Martin, C (2020).

SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.

EUROPEAN JOURNAL OF CANCER. Article. 135:242-250.
[doi:10.1016/j.ejca.2020.06.001]

Cabrera-Marante, O, Rodríguez de Frías E, Pleguezuelo, DE, Allende, LM, Serrano, A, Laguna-Goya, R, Mancebo, ME, Talayero, P, Alvarez-Vallina, L, Morales, P, Castro-Panete, MJ, Paz-Artal, E (2020).

Perforin gene variant A91V in young patients with severe COVID-19.

HAEMATOLOGICA. Letter. 105(12):2844-2846.
[doi:10.3324/haematol.2020.260307]

de Cossio, S, Labrador, B, Yarza, R, Corbella, L, Fernandez-Ruiz, M (2020).

Oesophageal ulcer: An uncommon presentation of tuberculous lymphadenitis mimicking an oesophageal carcinoma.

GASTROENTEROLOGIA Y HEPATOLOGIA. Letter. 43(3):133-134.
[doi:10.1016/j.gastrohep.2019.10.002]

Roda-Navarro, P, Alvarez-Vallina, L (2020).

Understanding the Spatial Topology of Artificial Immunological Synapses Assembled in T Cell-Redirecting Strategies: A Major Issue in Cancer Immunotherapy.

Frontiers In Cell And Developmental Biology. Article. 7:370-370.
[doi:10.3389/fcell.2019.00370]

Bover, M, Yarza, R, Docampo, LI (2020).

Four-Year Lasting Sustained Complete Response After Nivolumab in a Patient With Non-Small-Cell Lung Cancer and Confirmed Leptomeningeal Carcinomatosis: Changing the Paradigm.

CLINICAL LUNG CANCER. Article. 21(1):1-5.
[doi:10.1016/j.cllc.2019.07.012]

Blanco, B, Ramirez-Fernandez, A, Alvarez-Vallina, L (2020).

Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies.

Frontiers in immunology. Review. 11:1792-1792.
[doi:10.3389/fimmu.2020.01792]

2019

Soldevilla, B, Carretero-Puche, C, Gomez-Lopez, G, Al-Shahrour, F, Riesco, MC, Gil-Calderon, B, Alvarez-Vallina, L, Espinosa-Olarte, P, Gomez-Esteves, G, Rubio-Cuesta, B, Sarmentero, J, La Salvia, A, Garcia-Carbonero, R (2019).

The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.

EUROPEAN JOURNAL OF CANCER. Article. 123:118-129.
[doi:10.1016/j.ejca.2019.09.008]

Lopez-Gomez, V, Yarza, R, Munoz-Gonzalez, H, Revilta, E, Enrech, S, Gonzalez-Valle, O, Tolosa, P, Ciruelos, E (2019).

Ribociclib-Related Stevens-Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review

JOURNAL OF BREAST CANCER. Review. 22(4):661-666.
[doi:10.4048/jbc.2019.22.e44]

Lazaro-Gorines, R, Ruiz-de-la-Herran, J, Navarro, R, Sanz, L, Alvarez-Vallina, L, Martinez-del-Pozo, A, Gavilanes, JG, Lacadena, J (2019).

A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.

SCIENTIFIC REPORTS. Article. 9(1):11680-11680.
[doi:10.1038/s41598-019-48285-z]

Mikkelsen, K, Harwood, SL, Compte, M, Merino, N, Mølgaard K, Lykkemark, S, Alvarez-Mendez, A, Blanco, FJ, Alvarez-Vallina, L (2019).

Carcinoembryonic Antigen (CEA)-Specific 4-1BB-Costimulation Induced by CEA-Targeted 4-1BB-Agonistic Trimerbodies.

Frontiers in immunology. Article. 10:1791-1791.
[doi:10.3389/fimmu.2019.01791]

Rios, X, Compte, M, Gomez-Vallejo, V, Cossio, U, Baz, Z, Morcillo, MA, Ramos-Cabrer, P, Alvarez-Vallina, L, Llop, J (2019).

Immuno-PET Imaging and Pharmacokinetics of an Anti-CEA scFv-based Trimerbody and Its Monomeric Counterpart in Human Gastric Carcinoma-Bearing Mice.

MOLECULAR PHARMACEUTICS. Article. 16(3):1025-1035.
[doi:10.1021/acs.molpharmaceut.8b01006]

Blanco, B, Compte, M, Lykkemark, S, Sanz, L, Alvarez-Vallina, L (2019).

T Cell-Redirecting Strategies to 'STAb' Tumors: Beyond CARs and Bispecific Antibodies

TRENDS IN IMMUNOLOGY. Review. 40(3):243-257.
[doi:10.1016/j.it.2019.01.008]

2018

Compte, M, Harwood, SL, Munoz, IG, Navarro, R, Zonca, M, Perez-Chacon, G, Erce-Llamazares, A, Merino, N, Tapia-Galisteo, A, Cuesta, AM, Mikkelsen, K, Caleiras, E, Nunez-Prado, N, Aznar, MA, Lykkemark, S, Martinez-Torrecuadrada, J, Melero, I, Blanco, FJ, Bernardino de la Serna J, Zapata, JM, Sanz, L, Alvarez-Vallina, L (2018).

A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

NATURE COMMUNICATIONS. Article. 9(1):4809-4809.
[doi:10.1038/s41467-018-07195-w]